Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Therapeutic drug for treating uterine fibroid, adenomyosis, cervical polyp and human papillomavirus

A technology for adenomyosis and cervical polyps, which is applied in the field of gynecological therapeutic drugs, can solve problems such as difficult radical cure, and achieve the effect of simple materials, low cost and simple operation

Inactive Publication Date: 2019-04-26
罗梦芝
View PDF3 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

The treatment of this disease can be drug intervention or surgery, but it is difficult to cure. Only postmenopausal patients with adenomyosis can gradually relieve themselves

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] The invention provides a medicine for treating uterine fibroids, adenomyosis, cervical polyps and HPV, which comprises the following components: 15 parts of cistanche, 8 parts of Ganoderma lucidum, 8 parts of alum, 8 parts of wild ginseng, 8 parts of peach kernel, 15 parts of saffron, 15 parts of motherwort, 13 parts of borneol, 8 parts of sophora flavescens.

[0024] Its technical process includes the following steps:

[0025] S1. Selection of raw materials: select the components of the above-mentioned parts by weight as raw materials;

[0026] S2. Raw material pretreatment: cleaning the raw material in step S1, removing dust and impurities;

[0027] S3. Drying: drying the pretreated raw materials in step S2;

[0028] S4. Pulverization: Put the dried raw materials in step S3 into an ultrafine pulverizer for pulverization, and mix the raw material powders uniformly after pulverization to obtain drug powder;

[0029] S5. bag making: adopt suitable sterilized degreasin...

Embodiment 2

[0033] The invention provides a medicine for treating uterine fibroids, adenomyosis, cervical polyps and HPV, which comprises the following components: 20 parts of cistanche, 10 parts of Ganoderma lucidum, 10 parts of alum, 10 parts of wild ginseng, 20 parts of peach kernel, 20 parts of saffron, 20 parts of motherwort, 15 parts of borneol, and 10 parts of sophora.

[0034] Its technical process includes the following steps:

[0035] S1. Selection of raw materials: select the components of the above-mentioned parts by weight as raw materials;

[0036] S2. Raw material pretreatment: cleaning the raw material in step S1, removing dust and impurities;

[0037] S3. Drying: drying the pretreated raw materials in step S2;

[0038] S4. Pulverization: Put the dried raw materials in step S3 into an ultrafine pulverizer for pulverization, and mix the raw material powders uniformly after pulverization to obtain drug powder;

[0039] S5. bag making: adopt suitable sterilized degreasing ...

Embodiment 3

[0043] The invention provides a medicine for treating uterine fibroids, adenomyosis, cervical polyps and HPV, which comprises the following components: 10 parts of cistanche, 5 parts of Ganoderma lucidum, 5 parts of alum, 5 parts of wild ginseng, 10 parts of peach kernel, 10 parts of saffron, 10 parts of Motherwort, 10 parts of borneol, 5 parts of Sophora flavescens.

[0044] Its technical process includes the following steps:

[0045] S1. Selection of raw materials: select the components of the above-mentioned parts by weight as raw materials;

[0046] S2. Raw material pretreatment: cleaning the raw material in step S1, removing dust and impurities;

[0047] S3. Drying: drying the pretreated raw materials in step S2;

[0048] S4. Pulverization: put the dried raw materials in step S3 into an ultrafine pulverizer for pulverization, and mix the raw material powders uniformly after pulverization to obtain drug powder;

[0049]S5. bag making: adopt suitable sterilized degreasin...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
diameteraaaaaaaaaa
Login to View More

Abstract

The invention provides a therapeutic drug for treating uterine fibroid, adenomyosis, cervical polyp and human papillomavirus (HPV). The drug comprises the following components: 10-20 parts of herba boschniakia rossica, 5-10 parts of lucid ganoderma, 5-10 parts of alumen, 5-10 parts of wild ginseng, 10-20 parts of semen persicae, 10-20 parts of saffron, 10-20 parts of motherwort herb, 10-15 parts of borneol, and 5-10 parts of radix sophorae flavescentis. The drug has inhbiting effects on staphylococcus aureus, escherichia coli, candida albicans and human papillomavirus, and can be used for inhibiting and resisting microbes and daily bacteriostatic nursing of cleaning gynecological wastes in the treatment of uterine fibroid, adenomyosis, cervical polyp, human papillomavirus. The invention also provides a technological process for the therapeutic drug for treating uterine fibroid, adenomyosis, cervical polyp and human papillomavirus, and the process comprises selecting the raw materials,pretreating the raw materials, drying, pulverizing, bagging, packaging and warehousing, and the technological process is simple in operation, the raw materials are simple and easy to obtain, the costis low and the process is worth promoting.

Description

technical field [0001] The invention relates to the technical field of gynecological therapeutic drugs, in particular to a therapeutic drug for uterine fibroids, adenomyosis, cervical polyps and HPV. Background technique [0002] Uterine fibroids are the most common benign tumors in female reproductive organs and one of the most common tumors in the human body, also known as fibromyomas and uterine fibroids. Since uterine fibroids are mainly formed by the proliferation of uterine smooth muscle cells, a small amount of fibrous connective tissue exists as a supporting tissue, so it is more accurate to call it uterine leiomyoma, or uterine fibroids for short. [0003] Adenomyosis is a diffuse or localized lesion in which endometrial glands and stroma invade the myometrium. Like endometriosis, it is a common and difficult disease in gynecology. Adenomyosis mostly occurs in multiparous women aged 30 to 50, but it can also be seen in young nulliparous women, which may be related ...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K36/88A61P15/00A61P31/20A61P35/00A61K31/045A61K33/06
CPCA61K31/045A61K33/06A61K36/074A61K36/258A61K36/489A61K36/533A61K36/64A61K36/736A61K36/88A61P15/00A61P31/20A61P35/00A61K2300/00Y02A50/30
Inventor 罗梦芝
Owner 罗梦芝
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com